The administration of allergen immunotherapy by the sublingual route (sublingual immunotherapy) is increasingly used in Europe and is of increasing interest in the United States because of its convenient mode of delivery and greater safety, which allows for self-administration of treatment at home. In this issue of JAMA, Lin et al1 report results of a systematic review of sublingual immunotherapy for treatment of allergic asthma, rhinitis, and conjunctivitis.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 6
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.